Structural and Functional Characterization of Anti-A33 Antibodies Reveal a Potent Cross-Species Orthopoxviruses Neutralizer.
Vaccinia virus A33 is an extracellular enveloped virus (EEV)-specific type II membrane glycoprotein that is essential for efficient EEV formation and long-range viral spread within the host. A33 is a target for neutralizing antibody responses against EEV. In this study, we produced seven murine anti...
Main Authors: | Michael H Matho, Andrew Schlossman, Xiangzhi Meng, Mohammed Rafii-El-Idrissi Benhnia, Thomas Kaever, Mark Buller, Konstantin Doronin, Scott Parker, Bjoern Peters, Shane Crotty, Yan Xiang, Dirk M Zajonc |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-09-01
|
Series: | PLoS Pathogens |
Online Access: | http://europepmc.org/articles/PMC4556652?pdf=render |
Similar Items
-
Development of a High-Content Orthopoxvirus Infectivity and Neutralization Assays.
by: Irina Gates, et al.
Published: (2015-01-01) -
Murine anti-vaccinia virus D8 antibodies target different epitopes and differ in their ability to block D8 binding to CS-E.
by: Michael H Matho, et al.
Published: (2014-12-01) -
Differentiation of Orthopoxviruses
by: Harper, L.
Published: (1978) -
Ectromelia Virus Infections of Mice as a Model to Support the Licensure of Anti-Orthopoxvirus Therapeutics
by: R. Mark Buller, et al.
Published: (2010-09-01) -
Deficiency in Th2 cytokine responses exacerbate orthopoxvirus infection.
by: Isaac G Sakala, et al.
Published: (2015-01-01)